(Adnkronos) - "Il campo delle vaccinazioni è in continuo movimento, per questo l’innovazione è fondamentale. Aggiornare il calendario delle vaccinazioni ogni anno, in base ai nuovi prodotti o alle nuove popolazioni target che si vanno aggiungendo nel campo dell’influenza, è fondamentale. Tutte le regioni si stanno organizzando per poter dare la possibilità di accedere a un diritto fondamentale che è quello di proteggersi da una malattia stagionale come l'influenza, malattia tutt'altro che banale. È chiaro che dobbiamo cercare proprio di incentivare questo diritto alla protezione dall'influenza avendo e utilizzando i prodotti appropriati che oggi abbiamo in larga misura proprio nell'influenza”. Così Francesco Vitale, presidente del 57esimo Congresso nazionale Siti, Società italiana d’igiene medicina preventiva e sanità pubblica e professore ordinario di Igiene, Università di Palermo spiga gli obiettivi dell’evento.
Category
🗞
NewsTranscript
00:00The objectives are already in the title of the Congress, innovation, institutional strategies
00:10and synergies for prevention.
00:12It is a title that includes a bit of everything that we want to try to carry out in this National
00:17Hygiene Congress, that is, to ride those that are the innovations that today health care
00:22already needs.
00:23Innovations that are in the field of vaccination prevention, for screenings, for all that,
00:28for the environment, for food, and above all to create the assumptions to be able to
00:34confront us with the institutions, because the institutions, the allocation of resources
00:38today need public health, technically, as well as public health needs institutions
00:43to have good regulations.
00:45The field of vaccination is a field in continuous movement, in continuous dynamism, that's why
00:50innovation is fundamental, because we are now renewing with the new National Plan
00:55of Vaccine Prevention, 23-25, which has the function of being dynamic, to be able to update
01:02the calendar of immunizations, of vaccinations, every year, based on the new products or
01:09the new target populations that are being added.
01:11The field of influence is fundamental, we are in the opening of the annual vaccination campaign
01:16and all the regions are organizing to be able to provide, to be able to give the possibility
01:23of access to a fundamental right of all citizens, which is to protect themselves from a seasonal
01:28disease such as influenza, which is a disease that is far from banal, on the contrary, it is a
01:33challenging disease from the individual point of view, from the social point of view.
01:37It is clear that we must try to incentivize what this right to protection from influenza is,
01:45having and using the appropriate products, products that today we have to a large extent
01:51in the influence, because we know, for example, that the elderly, the over 60s, who must be
01:57vaccinated, because already only by age they have a greater risk of being able to contract
02:02influenza and to have more serious consequences from influenza, must be vaccinated with
02:07products that are adjuvants and still enhanced.
02:10Vaccines that we have and that must be given in an appropriate way, as well as for children,
02:15as well as for the population, as well as for the fragile and for the chronically ill,
02:18which we must also give products that are strong, whether on cell cultures or
02:25whether they are enhanced or adjuvants.
02:27So today's strategies are to improve vaccination coverage, which unfortunately has
02:33decreased after the first year when there was Covid, in which the fear of having influenza
02:38in contemporary with Covid had significantly improved vaccination coverage.
02:43I remember that we have a minimum target of 75% and an optimal target of 95%.
02:49We have not reached that minimum and we had improved in the first year of Covid, after
02:54which there was a bit of disaffection, a bit of fatigue due to vaccinations, to the entire
03:00media campaign that there was during Covid and this has also influenced other vaccinations.
03:04We must recover.
03:05We must recover how?
03:06By creating a will, a network at the territorial level, in the vaccination centers, with the
03:11doctors of general medicine, with the pediatrics of free choice.
03:14We have a tool that is being configured in a determining way, which is the national
03:21and regional vaccine anagraph.
03:23We use it, we use it to understand who has not been vaccinated, we use the active call
03:30and we go from a prevention of waiting to a prevention of initiative.
03:34Professor, as every year the Ministry of Health emits a circular ministry dedicated
03:39to the prevention of influenza.
03:40Can you describe it briefly?
03:42It is a circular that includes all the categories that are at greater risk for influenza and
03:48for all the categories we really mean almost the entire population, because we start from
03:52the over 60s by age, all those who have chronic diseases and therefore who are more exposed
03:58to a risk that can give more severe consequences of influenza and therefore we are talking about
04:02any chronic disease that in some way can undermine health in general and therefore
04:08can, in case of influenza, determine a greater severity.
04:12We are talking about pregnant women, in any trimester of pregnancy we can and we must
04:16vaccinate them for influenza, both for their protection and for the protection of the child,
04:20perfect.
04:22We must vaccinate all children in school age, because they are the ones who carry the
04:26influenza in the whole community, from grandparents to all the other people who are around them.
04:32We must vaccinate the hospitalized subjects, we must vaccinate the health workers who have
04:36to give the model and they have to be the first ones, as a duty of care, because they
04:42assist people who then turn to them to be cared for and therefore they cannot mix or
04:48infect an influenza that maybe they have underestimated to be able to go to work and
04:54provide their work.